This site is intended for healthcare professionals
News

Preliminary data shows that BNT 162b1 is safe and immunologically active in COVID-19.- Pfizer and BioNTech

Read time: 3 mins
Last updated:2nd Jul 2020
Published:2nd Jul 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com